IBDEI15G ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20284,1,4,0)
 ;;=4^Stricture of Artery
 ;;^UTILITY(U,$J,358.3,20284,1,5,0)
 ;;=5^447.1
 ;;^UTILITY(U,$J,358.3,20284,2)
 ;;=^114763
 ;;^UTILITY(U,$J,358.3,20285,0)
 ;;=355.71^^107^1255^28
 ;;^UTILITY(U,$J,358.3,20285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20285,1,4,0)
 ;;=4^Causalgia of Lower Limb
 ;;^UTILITY(U,$J,358.3,20285,1,5,0)
 ;;=5^355.71
 ;;^UTILITY(U,$J,358.3,20285,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,20286,0)
 ;;=444.89^^107^1255^16
 ;;^UTILITY(U,$J,358.3,20286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20286,1,4,0)
 ;;=4^Arterial Embolism NEC
 ;;^UTILITY(U,$J,358.3,20286,1,5,0)
 ;;=5^444.89
 ;;^UTILITY(U,$J,358.3,20286,2)
 ;;=^269793
 ;;^UTILITY(U,$J,358.3,20287,0)
 ;;=447.6^^107^1255^17
 ;;^UTILITY(U,$J,358.3,20287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20287,1,4,0)
 ;;=4^Arteritis NOS
 ;;^UTILITY(U,$J,358.3,20287,1,5,0)
 ;;=5^447.6
 ;;^UTILITY(U,$J,358.3,20287,2)
 ;;=^10396
 ;;^UTILITY(U,$J,358.3,20288,0)
 ;;=445.81^^107^1255^21
 ;;^UTILITY(U,$J,358.3,20288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20288,1,4,0)
 ;;=4^Atheroembolism,Kidney
 ;;^UTILITY(U,$J,358.3,20288,1,5,0)
 ;;=5^445.81
 ;;^UTILITY(U,$J,358.3,20288,2)
 ;;=^328516
 ;;^UTILITY(U,$J,358.3,20289,0)
 ;;=445.89^^107^1255^22
 ;;^UTILITY(U,$J,358.3,20289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20289,1,4,0)
 ;;=4^Atheroembolism,Other Site
 ;;^UTILITY(U,$J,358.3,20289,1,5,0)
 ;;=5^445.89
 ;;^UTILITY(U,$J,358.3,20289,2)
 ;;=^328517
 ;;^UTILITY(U,$J,358.3,20290,0)
 ;;=904.9^^107^1255^25
 ;;^UTILITY(U,$J,358.3,20290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20290,1,4,0)
 ;;=4^Blood Vessel Injury NOS
 ;;^UTILITY(U,$J,358.3,20290,1,5,0)
 ;;=5^904.9
 ;;^UTILITY(U,$J,358.3,20290,2)
 ;;=^275212
 ;;^UTILITY(U,$J,358.3,20291,0)
 ;;=682.9^^107^1255^29
 ;;^UTILITY(U,$J,358.3,20291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20291,1,4,0)
 ;;=4^Cellulitis NOS
 ;;^UTILITY(U,$J,358.3,20291,1,5,0)
 ;;=5^682.9
 ;;^UTILITY(U,$J,358.3,20291,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,20292,0)
 ;;=682.0^^107^1255^33
 ;;^UTILITY(U,$J,358.3,20292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20292,1,4,0)
 ;;=4^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,20292,1,5,0)
 ;;=5^682.0
 ;;^UTILITY(U,$J,358.3,20292,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,20293,0)
 ;;=682.1^^107^1255^34
 ;;^UTILITY(U,$J,358.3,20293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20293,1,4,0)
 ;;=4^Cellulitis of Neck
 ;;^UTILITY(U,$J,358.3,20293,1,5,0)
 ;;=5^682.1
 ;;^UTILITY(U,$J,358.3,20293,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,20294,0)
 ;;=682.2^^107^1255^35
 ;;^UTILITY(U,$J,358.3,20294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20294,1,4,0)
 ;;=4^Cellulitis of Trunk
 ;;^UTILITY(U,$J,358.3,20294,1,5,0)
 ;;=5^682.2
 ;;^UTILITY(U,$J,358.3,20294,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,20295,0)
 ;;=414.8^^107^1255^36
 ;;^UTILITY(U,$J,358.3,20295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20295,1,4,0)
 ;;=4^Chr Ischemic Hrt Disease NEC
 ;;^UTILITY(U,$J,358.3,20295,1,5,0)
 ;;=5^414.8
 ;;^UTILITY(U,$J,358.3,20295,2)
 ;;=^269680
 ;;^UTILITY(U,$J,358.3,20296,0)
 ;;=707.10^^107^1255^94
 ;;^UTILITY(U,$J,358.3,20296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20296,1,4,0)
 ;;=4^Ulcer of Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,20296,1,5,0)
 ;;=5^707.10
 ;;^UTILITY(U,$J,358.3,20296,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,20297,0)
 ;;=414.01^^107^1255^37
 ;;^UTILITY(U,$J,358.3,20297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20297,1,4,0)
 ;;=4^Cor Atheroscl Natv C Vsl
 ;;^UTILITY(U,$J,358.3,20297,1,5,0)
 ;;=5^414.01
 ;;^UTILITY(U,$J,358.3,20297,2)
 ;;=^303281
 ;;
 ;;$END ROU IBDEI15G
